These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1964471)
41. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950 [TBL] [Abstract][Full Text] [Related]
42. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma. Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841 [TBL] [Abstract][Full Text] [Related]
43. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma. Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588 [TBL] [Abstract][Full Text] [Related]
44. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease. Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243 [TBL] [Abstract][Full Text] [Related]
45. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Lüttges J; Vogel I; Menke M; Henne-Bruns D; Kremer B; Klöppel G Virchows Arch; 1998 Sep; 433(3):237-42. PubMed ID: 9769127 [TBL] [Abstract][Full Text] [Related]
46. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Nitecki SS; Sarr MG; Colby TV; van Heerden JA Ann Surg; 1995 Jan; 221(1):59-66. PubMed ID: 7826162 [TBL] [Abstract][Full Text] [Related]
47. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma. Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036 [TBL] [Abstract][Full Text] [Related]
48. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937 [TBL] [Abstract][Full Text] [Related]
49. Total pancreatectomy for ductal carcinoma of the head of the pancreas: current status. Castellanos J; Manifacio G; Lillehei RC; Shatney CH Am J Surg; 1976 May; 131(5):595-8. PubMed ID: 179436 [TBL] [Abstract][Full Text] [Related]
50. Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association Française de Chirurgie. Delpero JR; Boher JM; Sauvanet A; Le Treut YP; Sa-Cunha A; Mabrut JY; Chiche L; Turrini O; Bachellier P; Paye F Ann Surg Oncol; 2015; 22(6):1874-83. PubMed ID: 25665947 [TBL] [Abstract][Full Text] [Related]
51. Surgical treatment and prognosis of 96 cases of intraductal papillary mucinous neoplasms of the pancreas: a retrospective cohort study. Tian X; Gao H; Ma Y; Zhuang Y; Yang Y Int J Surg; 2015 Jan; 13():49-53. PubMed ID: 25461854 [TBL] [Abstract][Full Text] [Related]
52. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease. Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811 [TBL] [Abstract][Full Text] [Related]
53. Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital. Yamaguchi K; Shimizu S; Yokohata K; Noshiro H; Chijiiwa K; Tanaka M Hepatogastroenterology; 1999; 46(30):3257-62. PubMed ID: 10626197 [TBL] [Abstract][Full Text] [Related]
54. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size. Ohta T; Nagakawa T; Ueno K; Kayahara M; Mori K; Kobayashi H; Takeda T; Miyazaki I Int Surg; 1993; 78(3):208-12. PubMed ID: 8276542 [TBL] [Abstract][Full Text] [Related]
55. Efficacy of completion pancreatectomy for recurrence of adenocarcinoma in the remnant pancreas. Nakayama Y; Sugimoto M; Gotohda N; Konishi M; Takahashi S J Surg Res; 2018 Jan; 221():15-23. PubMed ID: 29229121 [TBL] [Abstract][Full Text] [Related]
56. Aggressive surgery for pancreatic duct cell cancer: feasibility, validity, limitations. Takahashi S; Ogata Y; Miyazaki H; Maeda D; Murai S; Yamataka K; Tsuzuki T World J Surg; 1995; 19(4):653-9; discussion 660. PubMed ID: 7676716 [TBL] [Abstract][Full Text] [Related]
57. [Subtotal duodenopancreatectomy. A new surgical technic for cancer of the pancreas head]. Gall FP Fortschr Med; 1984 Mar; 102(11):289-92. PubMed ID: 6325314 [TBL] [Abstract][Full Text] [Related]
58. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. Shimada K; Sakamoto Y; Sano T; Kosuge T J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307 [TBL] [Abstract][Full Text] [Related]
59. The results and problems of extensive radical surgery for carcinoma of the head of the pancreas. Nagakawa T; Konishi I; Ueno K; Ohta T; Akiyama T; Kanno M; Kayahara M; Miyazaki I Jpn J Surg; 1991 May; 21(3):262-7. PubMed ID: 1857030 [TBL] [Abstract][Full Text] [Related]
60. [Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports]. Chatelain D; Fléjou JF Ann Pathol; 2002 Oct; 22(5):422-31. PubMed ID: 12483163 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]